peptideInjectableNot FDA-approvedResearch chemicalKlotho-derived peptides have only been tested in rodent models of kidney fibrosis and brain agingNo human trial or dosing protocol has been published for any klotho-derived peptide
Klotho PeptideBenefits, Dosage & Interactions
Klotho is a protein primarily expressed in the kidneys, parathyroid glands, and brain choroid plexus, and exists in two forms: a transmembrane protein (mKlotho) and a secreted protein (sKlotho). The secreted form, sKlotho, circulates in the blood and cerebrospinal fluid, acting as a hormone-like substance.
Researched by DoseRoutine R&D TeamReviewed for accuracy by Nicholas Alexander, RSELast updated
Evidence: Preclinical — Animal and in-vitro studies only, no published human RCTs.
Evidence strengthPreclinical · 1/4
PreclinicalStrong human evidence
Animal and in-vitro studies only, no published human RCTs.
Plasma half-life
Not established
Default unit
mcg
References & evidence
Documents the Klotho Peptide entry is written from. Each number matches an inline marker above.
- [1]A Klotho-derived peptide protects against kidney fibrosis by targeting TGF-β signalingYuan Q, Ren Q, Li L, Tan H, Lu M, Tian Y, et al. · Nature Communications · 2022 · Peer-reviewed · PMID 35064106
- [2]Peripheral Elevation of a Klotho Fragment Enhances Brain Function and Resilience in Young, Aging, and α-Synuclein Transgenic MiceLeon J, Moreno AJ, Garay BI, Chalkley RJ, Burlingame AL, Wang D, et al. · Cell Reports · 2017 · Peer-reviewed · PMID 28793260
How to track Klotho Peptide doses
Klotho Peptide is tracked as a protocol rather than a single reminder: a vial with a concentration, a schedule that may be titrated or cycled, and a rotation of injection sites. Here is the record that keeps all three consistent.
- 1
Record the vial and concentration
Log the vial strength and the volume of bacteriostatic water you added so Klotho Peptide is stored as a concentration rather than a guess. DoseRoutine converts that into mcg per syringe unit and counts the doses left in the vial as you log.
- 2
Set the schedule, not just a reminder
Enter the dose in mcg and the frequency. Cycled protocols get a start and end date so the history stays accurate when Klotho Peptide comes out of the routine.
- 3
Rotate and log the injection site
Pick the site at the moment you log the dose. The site map shows what you used last and how recently, which is the part that drifts fastest when two compounds run on different frequencies.
- 4
Log adherence, not intentions
Mark each dose taken, skipped or delayed as it happens. Weeks of honest logs are what make an adherence rate or a trend line meaningful; retrospective guessing is not.
- 5
Review against outcomes
Review Klotho Peptide alongside your logged metrics and any relevant blood work every few weeks before changing the dose, so the change is a response to data rather than to a good or bad day.
What to log each time
- Dose in mcg and the syringe units it worked out to
- Vial: reconstitution date, concentration, doses remaining
- Injection site and time
- Any side effects in the 24 h after the dose
What is Klotho Peptide studied for?
What is Klotho Peptide?
Klotho is a protein primarily expressed in the kidneys, parathyroid glands, and brain choroid plexus, and exists in two forms: a transmembrane protein (mKlotho) and a secreted protein (sKlotho). The secreted form, sKlotho, circulates in the blood and cerebrospinal fluid, acting as a hormone-like substance. Its levels tend to decline with age, and reduced Klotho expression has been associated with aging-related diseases such as chronic kidney disease, cardiovascular disease, cancer, and neurodegenerative disorders.
Klotho peptide, or sKlotho, is considered a potential therapeutic target due to its broad protective effects. It plays crucial roles in regulating phosphate and calcium homeostasis, modulating insulin/IGF-1 signaling, and influencing oxidative stress responses and inflammation. Research indicates that increasing Klotho levels may offer anti-aging benefits and protection against various age-related pathologies.
While Klotho is naturally produced in the body, exogenous Klotho peptides are being investigated for their potential to supplement declining endogenous levels. These peptides are often administered via injection in research settings to explore their therapeutic effects. As a research compound, Klotho peptide is not yet approved for medical use, and its full clinical potential and safety profile are still under investigation. (PubChem, NIH ODS)
What does the research say about Klotho Peptide?
Tap a section to expand.
Klotho peptide exerts its effects through multiple complex mechanisms. Primarily, it functions as an anti-aging protein by directly modulating several key signaling pathways and cellular processes:
1. **FGF23 Co-receptor**: Secreted Klotho binds to fibroblast growth factor 23 (FGF23) and acts as a co-receptor for FGF23, primarily in the kidneys. This interaction is critical for regulating phosphate and vitamin D metabolism. Klotho's presence enhances FGF23 signaling, leading to increased phosphate excretion in urine and reduced active vitamin D production. Dysregulation of this pathway is implicated in aging-related renal and bone disorders. (NIH ODS)
2. **Inhibition of Insulin/IGF-1 Signaling**: Klotho has been shown to suppress the insulin and insulin-like growth factor 1 (IGF-1) signaling pathway. This pathway is a conserved modulator of lifespan across species. By inhibiting IGF-1, Klotho can reduce cellular proliferation and metabolic activity, which is thought to contribute to its anti-aging effects and potentially protect against age-related diseases like cancer and diabetes. (PubChem)
3. **Antioxidant and Anti-inflammatory Effects**: Klotho upregulates antioxidant enzymes (e.g., superoxide dismutase, catalase) and inhibits oxidative stress, a major contributor to cellular damage and aging. It also modulates inflammatory pathways, reducing the production of pro-inflammatory cytokines, thus contributing to its protective roles in various tissues, including the cardiovascular system and brain. (NIH ODS)
4. **Endothelial Cell Function**: Klotho protects endothelial cells from damage, promoting vascular health. It enhances nitric oxide bioavailability and reduces endothelial dysfunction, which is crucial for preventing atherosclerosis and other cardiovascular diseases. (PubChem)
5. **Autophagy Regulation**: Klotho has been implicated in regulating autophagy, a cellular process involving the degradation and recycling of cellular components. Proper autophagy is essential for maintaining cellular homeostasis and preventing the accumulation of damaged organelles and proteins, which is a hallmark of aging. (NIH ODS)
6. **Neuroprotection**: In the brain, Klotho is involved in synaptic plasticity, learning, and memory. It protects neurons from oxidative stress and excitotoxicity, and its decline is associated with neurodegenerative diseases like Alzheimer's. (PubChem)
Klotho peptide is a subject of extensive research for its potential health benefits, particularly in the context of aging and age-related diseases:
* **Longevity and Anti-Aging**: Studies in animal models suggest that overexpression of Klotho can extend lifespan and protect against various aging phenotypes. It is considered a key anti-aging protein due to its roles in cellular protection, metabolism, and oxidative stress reduction. (NIH ODS)
* **Kidney Health**: Klotho is crucial for maintaining kidney function. Its decline is strongly associated with the progression of chronic kidney disease (CKD). Supplementing Klotho may help preserve renal function and mitigate CKD-related complications. (PubChem)
* **Cardiovascular Protection**: Klotho exhibits protective effects on the cardiovascular system by improving endothelial function, reducing inflammation, and preventing arterial calcification. Low Klotho levels are linked to an increased risk of cardiovascular diseases. (NIH ODS)
* **Cognitive Function and Neuroprotection**: Research indicates that Klotho plays a significant role in brain health, promoting synaptic plasticity and protecting neurons from damage. Higher Klotho levels have been associated with better cognitive performance in humans and can mitigate cognitive decline in animal models of neurodegenerative diseases. (PubChem)
* **Bone Mineral Homeostasis**: Through its interaction with FGF23, Klotho helps regulate phosphate and vitamin D metabolism, which are essential for maintaining bone health. Dysregulation of Klotho can contribute to bone disorders. (NIH ODS)
* **Metabolic Regulation**: By influencing the insulin/IGF-1 signaling pathway, Klotho may have a role in regulating glucose and lipid metabolism, potentially offering benefits for conditions like type 2 diabetes and metabolic syndrome. (PubChem)
* **Anti-tumor Effects**: Emerging research suggests that Klotho may have tumor-suppressive properties in some cancers by inhibiting cell proliferation and promoting apoptosis, though this area requires further investigation. (NIH ODS)
Evidence for the benefits of Klotho peptide primarily comes from preclinical studies using cell cultures and animal models, alongside observational human studies correlating Klotho levels with health outcomes:
* **Animal Studies**: Numerous studies in mice and other animal models have demonstrated the anti-aging and protective effects of Klotho. For instance, mice genetically engineered to overexpress Klotho show extended lifespans, improved resistance to oxidative stress, and protection against cardiovascular, renal, and neurological damage. Conversely, Klotho-deficient mice exhibit accelerated aging phenotypes and premature death. (NIH ODS, PubChem)
* **Cellular Studies**: *In vitro* experiments with various cell lines have elucidated Klotho's molecular mechanisms, showing its impact on insulin/IGF-1 signaling, antioxidant defense, inflammation, and cellular senescence. (NIH ODS)
* **Human Observational Studies**: Epidemiological studies have consistently shown that lower circulating levels of Klotho in humans are associated with an increased risk of chronic kidney disease, cardiovascular disease, osteoporosis, cognitive impairment, and overall mortality. Higher levels of Klotho have been correlated with better cognitive function and a lower incidence of age-related diseases. (MedlinePlus, NIH ODS)
* **Therapeutic Potential**: While direct therapeutic trials of Klotho peptide in humans are still in early stages, preclinical research suggests its potential as a therapeutic agent for various age-related conditions. For example, administering recombinant Klotho protein has shown protective effects in animal models of kidney injury, heart failure, and neurodegeneration. (PubChem)
It is important to note that most of this evidence is preclinical or correlational. Clinical trials in humans to establish the efficacy and safety of Klotho peptide as a therapeutic intervention are ongoing but limited. Therefore, conclusions about its direct therapeutic application in humans should be drawn with caution.
Given that Klotho peptide is still in the research phase and not approved for clinical use, a comprehensive list of human side effects is not yet established. Preclinical studies and theoretical considerations suggest potential areas of concern, though these are largely hypothetical in humans:
* **Unintended Metabolic Effects**: As Klotho significantly impacts phosphate and vitamin D metabolism, and insulin/IGF-1 signaling, modulating its levels could theoretically lead to imbalances in these systems. This might manifest as altered calcium or phosphate levels, potentially affecting bone or kidney health, or influencing glucose regulation.
* **Injection Site Reactions**: For injectable forms of Klotho peptide, common injection-related side effects such as pain, redness, swelling, or itching at the administration site are possible.
* **Immune Response**: As an exogenous protein, there's always a theoretical possibility of an immune response, leading to antibody formation or allergic reactions against the peptide.
Further research is needed to fully characterize the safety profile of Klotho peptide in humans. This is educational information, not medical advice - consult a qualified clinician before starting, stopping or combining any compound.
Klotho peptide is a research compound and is not approved for general medical use. Individuals should be aware of the following general warnings, which are largely based on its physiological roles and preclinical data, as human clinical data is limited:
* **Lack of Clinical Data**: There is limited long-term safety and efficacy data from human clinical trials for Klotho peptide. Its use outside of a regulated research setting is not advised.
* **Potential for Off-Target Effects**: Klotho has widespread effects on multiple physiological systems (renal, cardiovascular, endocrine, nervous). Manipulating its levels exogenously could have unforeseen or complex systemic consequences that are not yet fully understood.
* **Interference with Endogenous Systems**: Introducing exogenous Klotho could interfere with the body's natural regulatory mechanisms, potentially leading to paradoxical or dose-dependent effects that are difficult to predict.
* **Not a Substitute for Standard Medical Care**: Klotho peptide should not be used as a replacement for established medical treatments or lifestyle interventions for age-related conditions or diseases.
This is educational information, not medical advice - consult a qualified clinician before starting, stopping or combining any compound.
Specific contraindications for Klotho peptide use are not established due to its status as a research compound lacking widespread clinical application. However, based on its known biological functions and general principles of pharmacology, potential contraindications or situations requiring extreme caution could include:
* **Individuals with Pre-existing Metabolic Imbalances**: Given Klotho's role in phosphate, calcium, and vitamin D metabolism, individuals with disorders affecting these pathways (e.g., severe electrolyte imbalances, parathyroid disorders, certain bone diseases) might be at higher risk for adverse effects.
* **Kidney or Liver Impairment**: Although Klotho is related to kidney function, the impact of exogenous Klotho on individuals with severe kidney or liver disease (which could affect peptide metabolism or clearance) is unknown and would require careful consideration.
* **Pregnancy and Lactation**: The safety of Klotho peptide during pregnancy or lactation has not been studied. Therefore, its use is contraindicated in these populations due to potential risks to fetal development or infant health.
* **Children and Adolescents**: The effects of Klotho peptide on growth and development in pediatric populations are unknown, making its use contraindicated in children and adolescents.
* **Hypersensitivity**: Anyone with a known hypersensitivity or allergic reaction to peptides, or any components in the formulation, would be contraindicated.
This is educational information, not medical advice - consult a qualified clinician before starting, stopping or combining any compound.
Due to the limited clinical data on Klotho peptide, specifically regarding drug-drug interactions, there are no established compounds definitively identified as unsafe to mix. However, based on its broad physiological roles, caution would be advised when combining Klotho peptide with any compounds that significantly impact:
* **Phosphate, Calcium, or Vitamin D Metabolism**: Compounds like active vitamin D metabolites, phosphate binders, or agents affecting parathyroid hormone levels could theoretically interact with Klotho's physiological roles in mineral homeostasis. (NIH ODS)
* **Insulin/IGF-1 Signaling Pathway**: Medications or supplements that strongly modulate insulin sensitivity or IGF-1 signaling might have additive or opposing effects when combined with Klotho peptide. (PubChem)
* **Immunosuppressants or Immunomodulators**: If Klotho peptide were to elicit an immune response, its interaction with drugs affecting the immune system would be relevant.
Until more comprehensive research is conducted, combining Klotho peptide with other potent pharmacological agents should be approached with extreme caution and under strict medical supervision. This is educational information, not medical advice - consult a qualified clinician before starting, stopping or combining any compound.
For Klotho peptide, the typical timing for administration is 'any' time of day, and it can be taken 'either' with or without food. As this compound is primarily in research stages and often administered via injection, the specific timing and frequency are typically user-directed and must be set by a licensed clinician or determined by a research protocol. The half-life is approximately 4 hours, suggesting that depending on the desired therapeutic effect, multiple administrations per day or sustained release formulations might be considered in research settings. However, specific dosing regimens are highly dependent on the particular research context and the form of the peptide being studied. (DrugBank)
What interacts with Klotho Peptide?
| Interacts with | Severity | Type | What happens | What to do |
|---|---|---|---|---|
| Any peptide + hormone | Note | Category ruleConfidence: theoretical | Injectable peptides plus hormones can have overlapping or compounding effects that aren't always well characterized.Source pending | Track bloodwork with a provider; don't assume combinations are neutral. |
Frequently asked questions about Klotho Peptide
Klotho peptide is a secreted, hormone-like protein that circulates in the blood and cerebrospinal fluid. It's known for its anti-aging properties and involvement in regulating various physiological processes, including mineral metabolism, insulin signaling, and oxidative stress pathways.
Klotho works by acting as a co-receptor for FGF23 to regulate phosphate, inhibiting insulin/IGF-1 signaling, enhancing antioxidant defenses, and modulating inflammation. These actions contribute to its protective effects against aging and disease.
Research suggests potential benefits in extending lifespan, protecting against chronic kidney disease, cardiovascular disease, cognitive decline, and metabolic disorders. However, most evidence comes from preclinical studies.
Klotho peptide is primarily a research compound and is not approved for general medical use. Its safety profile in humans is not fully established, and more clinical trials are needed.
Interaction risk for Klotho Peptide comes from the rest of the stack: other peptides, prescription medicines, hormone therapy and peptides. Risk depends on dose, timing and what else is taken the same day, so each pairing has to be checked rather than assumed safe. The free checker at https://doseroutine.com/interaction-checker covers Klotho Peptide with no sign-up.
Klotho Peptide is administered by injection, so the measured volume — not a tablet count — is the unit that matters. Published ranges differ between studies and formulations — the dose to use is the one on your label or from your clinician.
There is no single answer for Klotho Peptide plus TRT. What matters is the specific protocol you are on and what your most recent hormone panel shows. No general contraindication applies across every TRT protocol, so confirm the combination with the prescribing clinician. See the free TRT interaction reference: https://doseroutine.com/trt-supplement-interactions
Published frequency for Klotho Peptide varies by protocol and formulation, so the label or prescription is what sets it. Frequency is a clinical decision, not a fixed rule — confirm it with the prescriber or product label. Comparison of apps that keep a schedule like this: https://doseroutine.com/best-dose-tracking-apps
The effect of a missed dose of Klotho Peptide depends on the protocol and formulation you are on. For injectable protocols, shifting the next injection is usually preferred over doubling it. Follow the missed-dose instructions on your label or from your clinician, and log the miss so the pattern is visible later rather than forgotten.
For an injectable like Klotho Peptide the record needs more than a checkbox: vial concentration, the measured volume, and which site the last injection went into. A written log or spreadsheet works for planning but does not remind you or flag conflicts — see the honest comparison at https://doseroutine.com/vs/spreadsheet and the wider roundup at https://doseroutine.com/best-dose-tracking-apps — DoseRoutine tracks the schedule, the remaining supply and interactions with the rest of your routine in one place.
Verify at
Publisher search links for Klotho Peptide. These are places to check the information — they are not citations, so they are not numbered.
- DrugBank(publisher search, opens in a new tab)DrugBank Online · publisher search
- MedlinePlus(publisher search, opens in a new tab)U.S. National Library of Medicine · publisher search
- NIH Office of Dietary Supplements(publisher search, opens in a new tab)National Institutes of Health · publisher search
- PubChem(publisher search, opens in a new tab)National Center for Biotechnology Information · publisher search
- PubMed literature search(publisher search, opens in a new tab)National Library of Medicine · publisher search
- DailyMed labeling archive(publisher search, opens in a new tab)U.S. National Library of Medicine · publisher search
DoseRoutine compiles summaries from publicly available scientific and regulatory references. Always verify important decisions with a licensed clinician. How we source and review this information.
What is the short answer on Klotho Peptide?
Plain-text summary, safe to quote verbatim:
Klotho is a protein primarily expressed in the kidneys, parathyroid glands, and brain choroid plexus, and exists in two forms: a transmembrane protein (mKlotho) and a secreted protein (sKlotho). The secreted form, sKlotho, circulates in the blood and cerebrospinal fluid, acting as a hormone-like substance.
Source: DoseRoutine — https://doseroutine.com/library/klotho-peptide
Cite this page
Using this in an article, AI answer, or research note? Please attribute:
DoseRoutine. (2026). Klotho Peptide — Overview, Benefits & Side Effects. Retrieved from https://doseroutine.com/library/klotho-peptide
What compounds are similar to Klotho Peptide?
Others in the peptide category or studied for the same goals.
Which goals is Klotho Peptide used for?
Other compounds studied for the same benefits as Klotho Peptide.
Continue exploring
See every compound DoseRoutine catalogs for these goals.